Last reviewed · How we verify

NCT04725786: PRECOSS

Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma - Pilot Study

Completed NA Last updated 22 December 2025
What this trial tests

NA trial testing thoracic echography in Systemic Sclerosis in 30 participants. Completed in 8 June 2022.

Timeline
17 March 2021
Primary endpoint
8 June 2022
8 June 2022

Quick facts

Lead sponsorUniversity Hospital, Tours
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment30
Start date17 March 2021
Primary completion8 June 2022
Estimated completion8 June 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Tours

Who can join

Adults 18 to 100, any sex, with Systemic Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diffuse interstitial lung disease (PID) is the leading cause of death in systemic scleroderma (SSc). Major progress has recently been made in its therapeutic management. Early diagnosis is essential to optimize this management. Current diagnostic techniques are based on high-resolution computed tomography on the thorax (HRCT) and pulmonary functional tests (PFT). However, these explorations have their limitations. Thus, there is a need for new techniques for a very early diagnosis of PID-SSc. Thoracic ultrasound (TUS) is an innovative, easily accessible, non-irradiating, inexpensive and painless tool. It is an emerging technique for the diagnosis of PID and has already proven its sensitivity for the detection of interstitial damage, as defined by HRCT. The main objective of the PRECOSS study is to describe the prevalence of an ultrasound interstitial syndrome in patients with SSc, free of PID-SSc (defined by the Goh criteria) detectable by HRCT.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. High Prevalence of the Lung Ultrasound Interstitial Syndrome in Systemic Sclerosis Patients with Normal HRCT and Lung Function-A Pilot Study.
    Mercier C, Thoreau B, Flament T, Legué S, et al · · 2024 · cited 1× · PMID 38792426 · DOI 10.3390/jcm13102885

Verify or expand the search:

Other recruiting trials for Systemic Sclerosis

Currently open trials in the same condition.

Other University Hospital, Tours trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04725786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing